T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPTX
1076
DELISTED
Repare Therapeutics
RPTX
| $27.1M | ﹤0.01% |
1,935,440
-152,905
| -7% | -$1.8M |
|
1077
Brighthouse Financial
BHF
$3.42B
| $27.1M | ﹤0.01% |
660,021
-2,327,250
| -78% | -$112M |
|
1078
Kimbell Royalty Partners
KRP
$1.52B
| $27.1M | ﹤0.01% |
1,726,554
-29,361
| -2% | -$511K |
|
|
DRE
1079
DELISTED
Duke Realty Corp.
DRE
| $27.1M | ﹤0.01% |
492,293
-570,317
| -54% | -$31.2M |
|
1080
Fortune Brands Innovations
FBIN
$5.78B
| $26.9M | ﹤0.01% |
526,530
-20,412
| -4% | -$1.2M |
|
1081
PROG Holdings
PRG
$1.7B
| $26.9M | ﹤0.01% |
1,629,088
-4,105,682
| -72% | -$105M |
|
1082
Cirrus Logic
CRUS
$6.08B
| $26.8M | ﹤0.01% |
369,199
+2,153
| +0.6% | +$167K |
|
1083
Frontier Group Holdings
ULCC
$1.57B
| $26.6M | ﹤0.01% |
2,837,680
+1,938,222
| +215% | +$19.6M |
|
1084
Hilton Grand Vacations
HGV
$3.49B
| $26.6M | ﹤0.01% |
744,066
-33,617
| -4% | -$1.5M |
|
1085
Diageo
DEO
$52.8B
| $26.6M | ﹤0.01% |
152,564
+1,878
| +1% | +$357K |
|
1086
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $26.6M | ﹤0.01% |
803,715
-778,266
| -49% | -$26M |
|
1087
Mid-America Apartment Communities
MAA
$15.6B
| $26.5M | ﹤0.01% |
151,730
-16,694
| -10% | -$3.1M |
|
1088
Array Technologies
ARRY
$796M
| $26.4M | ﹤0.01% |
2,396,374
+361,460
| +18% | +$3.57M |
|
|
PVBC
1089
DELISTED
Provident Bancorp
PVBC
| $26.3M | ﹤0.01% |
1,676,918
-668
| -0% | -$10.4K |
|
|
PPL
1090
PPL Corp
PPL
$26.8B
| $26.3M | ﹤0.01% |
967,742
-98,511
| -9% | -$2.83M |
|
1091
Insteel Industries
IIIN
$634M
| $26.1M | ﹤0.01% |
776,114
-500,686
| -39% | -$19.9M |
|
1092
Middlesex Water
MSEX
$1.11B
| $26M | ﹤0.01% |
296,979
-560,643
| -65% | -$50.3M |
|
1093
IDEAYA Biosciences
IDYA
$3.53B
| $26M | ﹤0.01% |
1,886,252
-228,741
| -11% | -$2.54M |
|
1094
WIX.com
WIX
$3.35B
| $26M | ﹤0.01% |
396,648
-1,109
| -0.3% | -$81.2K |
|
1095
Commault Systems
CVLT
$6.26B
| $26M | ﹤0.01% |
412,988
-222,366
| -35% | -$13.8M |
|
1096
Conduent
CNDT
$252M
| $25.9M | ﹤0.01% |
6,003,267
+5,881,958
| +4,849% | +$29.5M |
|
1097
CONMED
CNMD
$1.49B
| $25.9M | ﹤0.01% |
270,548
+2,187
| +0.8% | +$262K |
|
|
IMGO
1098
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $25.7M | ﹤0.01% |
1,920,310
-251,925
| -12% | -$4M |
|
1099
The Mosaic Company
MOS
$6.92B
| $25.6M | ﹤0.01% |
542,472
-35,370
| -6% | -$2.17M |
|
1100
Darden Restaurants
DRI
$25.4B
| $25.5M | ﹤0.01% |
225,124
+37,311
| +20% | +$4.66M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.